US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jan 15, 2020 (7 years ago)

Cholecalciferol

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

What was recalled

Cholecalciferol (Vitamin D3) Injection, VITAMIN D3 [P] 100,000 IU/ML INJECTABLE, For IM Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0251-3

Recalling firm
Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical
NDC code
71283-0251-3
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0993-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Cholecalciferol recalls

See all
Class II · Moderate risk Terminated

Cholecalciferol

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0198-2023
Class II · Moderate risk Terminated

Vitamin D3 Cholecalciferol 50

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. NDC 75834-020-12 D-0532-2021
Class II · Moderate risk Terminated

Vitamin D3 Cholecalciferol 50

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. NDC 75834-020-01 D-0531-2021
Class II · Moderate risk Terminated

Cholecalciferol

Reason Lack of Assurance of Sterility

Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0210-3 D-0992-2020
Class I · High risk Ongoing

Vitamin Supplement

Reason Superpotent Drug: The vitamin supplement contains an extremely high level of vitamin D3 (Cholecalciferol).

Glades Drugs Inc. D-0669-2016